Erwan Donal, ESC 2022: The TriClip bRIGHT study for symptomatic patients with severe tricuspid regurgitation
The bRIGHT study aimed to evaluate the safety and effectiveness of the TriClip device in symptomatic patients with severe tricuspid regurgitation. In this touchCARDIO interview, we speak with Professor Erwan Donal (University Hospital of Rennes, Rennes, France) to discuss tricuspid transcatherter edge-to-edge repair, the difficulty in patient selection and the purpose and conclusions of the TriClip bRIGHT study.
The abstract entitled ‘Impact of coaptation gap location on procedural strategy and outcomes following tricuspid transcatheter edge-to-edge repair: insights from the TriClip bRIGHT study’ was presented at the European Society of Cardiology (ESC) Congress 2022, 26 – 29 August 2022.
- Could you give us a brief overview of tricuspid transcatherter edge-to-edge repair and its clinical impact? (0:40)
- What are the challenges of patient selection for this procedure? (2:03)
- What were the objectives of the TriClip bRIGHT study? (3:27)
- How did procedural and short-term outcomes vary according to coaptation gap location? (4:23)
- What were the conclusions of the investigators? (5:49)
Disclosures: Erwan Donal is on the advisory board for Abbott; GE healthcare and Pfizer and has received honoraria from Alnylam, Bristol Myer Squibb and Pfizer. CHU Rennes has a research contract with Abbott structural.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of ESC 2022
Access more content on Devices here and Interventional Cardiology here
Share this Video
Related Videos In Interventional Cardiology
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
Hyo-Soo Kim, ACC 2023: Guidelines for the use of short-term dual antiplatelet therapy after coronary intervention
The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient’s clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea) to discuss the current guidelines for the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!